Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Henryschein Dental Company (NQ:HSIC)

68.55 +1.18 (+1.75%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Henryschein Dental Company

< Previous 1 2 3 4 5 6 Next >
What Does the Market Think About Henry Schein?
 
Via Benzinga
Dental Equipment & Technology Stocks Q1 Highlights: Henry Schein (NASDAQ:HSIC)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Henry Schein (NASDAQ:HSIC) and the best and... 
Via StockStory
3 Unpopular Stocks with Mounting Challenges
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can... 
Via StockStory
The Smart Money Is Buying These 10 Stocks
 
Via Benzinga
Earnings Scheduled For May 5, 2025
 
Via Benzinga
Breaking Down Henry Schein: 7 Analysts Share Their Views
 
Via Benzinga
Earnings Scheduled For February 25, 2025
 
Via Benzinga
Is Henry Schein Gaining or Losing Market Support?
 
Via Benzinga
Exploring the top movers within the S&P500 index during today's session.
Stay updated with the movements of the S&P500 index in the middle of the day on Tuesday. Discover which stocks are leading as top gainers and losers in today's session. 
Via Chartmill
HSIC Q1 Earnings Call: Henry Schein Navigates Flat Revenue with Margin Resilience and Strategic Shifts
Dental and medical products company Henry Schein (NASDAQ:HSIC) missed Wall Street’s revenue expectations in Q1 CY2025, with sales flat year on year at $3.17 billion. Its non-GAAP profit of $1.15 per... 
Via StockStory
Topics Supply Chain World Trade
3 Dawdling Stocks with Questionable Fundamentals
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
What 6 Analyst Ratings Have To Say About Henry Schein
 
Via Benzinga
These Analysts Lower Their Forecasts On Henry Schein Following Q1 Results
 
Via Benzinga
Stocks Pause Gains As Treasury Yields Rise: What's Driving Markets Monday?
Wall Street kicked off the week with a cautious tone, as major stock indices hovered near the flatline by midday in New York. Investors digested fresh signs of inflationary pressure in the services... 
Via Benzinga
Henry Schein's Reports Mixed Bag Q1 Earnings, CEO Confident In Business Fundamentals
Henry Schein affirms 2025 EPS outlook and projects 2%–4% sales growth, recording $25 million in restructuring costs in Q1 2025. 
Via Benzinga
US Stocks Likely To Open Lower After S&P 500's 9-Day Streak: 'Any De-Escalation In Trade Tensions Should Be Positive,' Says Expert
U.S. stock futures fell on Monday after a nine-day winning streak on the S&P 500 index. Futures of benchmark indices were lower in premarket. 
Via Benzinga
Topics Stocks World Trade
Henry Schein (NASDAQ:HSIC) Reports Sales Below Analyst Estimates In Q1 Earnings
Dental and medical products company Henry Schein (NASDAQ:HSIC) missed Wall Street’s revenue expectations in Q1 CY2025, with sales flat year on year at $3.17 billion. Its non-GAAP profit of $1.15 per... 
Via StockStory
Tyson Foods, Ford And 3 Stocks To Watch Heading Into Monday
 
Via Benzinga
Earnings To Watch: Henry Schein (HSIC) Reports Q1 Results Tomorrow
Dental and medical products company Henry Schein (NASDAQ:HSIC) will be announcing earnings results tomorrow before the bell. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
Q4 Rundown: Dentsply Sirona (NASDAQ:XRAY) Vs Other Dental Equipment & Technology Stocks
Let’s dig into the relative performance of Dentsply Sirona (NASDAQ:XRAY) and its peers as we unravel the now-completed Q4 dental equipment & technology earnings season. 
Via StockStory
Q4 Earnings Highs And Lows: Envista (NYSE:NVST) Vs The Rest Of The Dental Equipment & Technology Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Envista (NYSE:NVST) and the best and worst... 
Via StockStory
3 Reasons to Sell HSIC and 1 Stock to Buy Instead
Since September 2024, Henry Schein has been in a holding pattern, floating around $72.51. 
Via StockStory
Dental Equipment & Technology Stocks Q4 Earnings Review: Align Technology (NASDAQ:ALGN) Shines
Let’s dig into the relative performance of Align Technology (NASDAQ:ALGN) and its peers as we unravel the now-completed Q4 dental equipment & technology earnings season. 
Via StockStory
3 Small-Cap Stocks Walking a Fine Line
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
Via StockStory
Dental Equipment & Technology Stocks Q4 In Review: Henry Schein (NASDAQ:HSIC) Vs Peers
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Henry Schein (NASDAQ:HSIC) and the best and... 
Via StockStory
Top S&P500 movers in Wednesday's session
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Wednesday. 
Via Chartmill
CrowdStrike To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Wednesday
 
Via Benzinga
Henry Schein Q4 Earnings And Outlook Miss Expectations, Restructures For Growth
Henry Schein Q4 sales grew 5.8% to $3.19 billion, missing estimates. The company was restructured into three segments. 
Via Benzinga
Henry Schein (NASDAQ:HSIC) Reports Sales Below Analyst Estimates In Q4 Earnings
Dental and medical products company Henry Schein (NASDAQ:HSIC) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 5.8% year on year to $3.19 billion. Its non-GAAP profit of $1.19... 
Via StockStory
Henry Schein (HSIC) Q4 Earnings Report Preview: What To Look For
Dental and Medical products company Henry Schein (NASDAQ:HSIC) will be reporting results tomorrow morning. Here’s what investors should know. 
Via StockStory
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.